Microarrays have been described as a technology that will revolutionise medicine with the ultimate goal to develop effective treatments or cures for every human disease by 2050 (Ioannidis, 2005a). It ...

Zeptosens AG and ViaLogy Corp. today announced the results from an extensive, blinded study using Zeptosens' planar waveguide (PWG) based microarray technology and Vialogy's Quantum Resonance ...

A study funded by the National Cancer Institute, part of the National Institutes of Health, shows for the first time that microarray data generated in different laboratories can produce highly ...

Treatment options for localized prostate cancer are many and varied, ranging from immediate radical surgery through to observation alone. Radical prostatectomy has been shown to have an overall ...

An ultra-high-density protein microarray for high throughput single-tier serological detection of Lyme disease "We designed this platform to bring scale, speed, and precision to infectious disease ...

A substantial percentage of microarray-based studies in oncology contain critical flaws in analysis or in their conclusions, reports a study in the Jan. 17 issue of the Journal of the National Cancer ...

Sensitivity: 97.4% Specificity: 100% Positive Predictive Value (PPV): 100% Negative Predictive Value (NPV): 99.4% For 8 copy number variants (CNVs) detected by CMA, OGM defined their location and ...

The Microarray Innovations in Leukemia study assessed the clinical utility of gene expression profiling as a single test to subtype leukemias into conventional categories of myeloid and lymphoid ...

SAN DIEGO, Sept. 28, 2023 (GLOBE NEWSWIRE) -- Bionano Genomics (BNGO), Inc. today announced the publication of the first peer-reviewed benchmarking study to compare optical genome mapping (OGM) to the ...

KRAS mutation in the primary or acquired resistance of Chinese NSCLC to EGFR tyrosine kinase inhibitors No significant financial relationships to disclose. This is an ASCO Meeting Abstract from the ...

SANTA CLARA, Calif.--(BUSINESS WIRE)-- Agilent Technologies Inc. (NYSE: A) today announced that the United States-Latin American Cancer Research Network (US-LACRN) has selected Agilent Gene Expression ...